Results for insulin resistance

Publications & Outputs

1. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

   Reich, N. & Hölscher, C., 1/09/2022, In: Frontiers in Neuroscience. 16, 55 p., 970925.

   Research output: Contribution to Journal/Magazine › Review article › peer-review

2. A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease

   Kyrtata, N., Emsley, H. C. A., Sparasci, O., Parkes, L. M. & Dickie, B. R., 20/05/2021, In: Frontiers in Neuroscience. 15, 15 p., 626636.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

3. Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease.

   Reich, N. & Hölscher, C., 14/12/2020, In: Frontiers in Neuroscience. 14, 35 p., 614828.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

4. TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

   Pushpakom, S., Kolamunnage-Dona, R., Taylor, C., Foster, T., Spowart, C., García-Fiñana, M., Kemp, G. J., Jaki, T., Khoo, S., Williamson, P. & Pirmohamed, M., 15/05/2020, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 70, 10, p. 2062-2072 11 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

5. Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases

   Li, Y., Li, L. & Holscher, C., 10/2016, In: Reviews in the Neurosciences. 27, 7, p. 689-711 23 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review